Hofvind S, Geller B, Skaane P
Department of Screening-Based Research, Cancer Registry of Norway, Oslo, Norway.
Acta Radiol. 2008 Nov;49(9):975-81. doi: 10.1080/02841850802403730.
Interval cancers are considered a shortcoming in screening mammography due to less favorable prognostic tumor characteristics compared to screening-detected cancers and consequently a lower chance of survival from the disease.
To describe the mammographic features and prognostic histopathological tumor characteristics of interval breast cancers.
A total of 231 interval breast cancer cases diagnosed in prevalently screened women aged 50-69 years old were examined. Thirty-five percent of the cases were retrospectively classified as missed cancers, 23% as minimal sign, and 42% as true negative (including occult cancers) in a definitive classification performed by six experienced breast radiologists. The retrospective classification described the mammographic features of the baseline screening mammograms in missed and minimal-sign interval cancers, while histopathological reports were used to describe the tumor characteristics in all the subgroups of interval cancers.
Fifty percent of the missed and minimal-sign interval cancers combined presented poorly defined mass or asymmetric density, and 26% calcifications with or without associated density or mass at baseline screening. Twenty-seven percent of invasive tumors were <15 mm for missed and 47% for true interval cancers (P<0.001). Lymph node involvement was more common in missed (49%) compared with the true cases (33%, P<0.05).
Missed interval cancers have less prognostically favorable histopathological tumor characteristics compared with true interval cancers. Improving the radiologist's perception and interpretation by establishing systematic collection of features and implementation of organized reviews may decrease the number of interval cancers in a screening program.
由于与筛查发现的癌症相比,间期癌的肿瘤预后特征较差,因此其疾病生存率较低,所以间期癌被认为是乳腺钼靶筛查中的一个不足之处。
描述间期乳腺癌的钼靶特征和预后组织病理学肿瘤特征。
对在50 - 69岁接受普查的女性中诊断出的231例间期乳腺癌病例进行了检查。在由六位经验丰富的乳腺放射科医生进行的最终分类中,35%的病例被回顾性分类为漏诊癌,23%为微小征象,42%为真阴性(包括隐匿性癌)。回顾性分类描述了漏诊和微小征象间期癌基线筛查钼靶片的钼靶特征,而组织病理学报告用于描述所有间期癌亚组的肿瘤特征。
漏诊和微小征象间期癌合并病例中有50%表现为边界不清的肿块或不对称密度,26%在基线筛查时有钙化,伴或不伴有相关密度或肿块。漏诊的浸润性肿瘤中27% < 15 mm,真间期癌中为47%(P < 0.001)。与真病例(33%,P < 0.05)相比,漏诊病例中淋巴结受累更为常见(49%)。
与真间期癌相比,漏诊的间期癌具有预后较差的组织病理学肿瘤特征。通过建立系统的特征收集和实施有组织的复查来提高放射科医生的认知和解读能力,可能会减少筛查项目中间期癌的数量。